Skip to main content
Top
Published in: Malaria Journal 1/2012

Open Access 01-12-2012 | Research

Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates

Authors: Jung-Mi Kang, Hye-Lim Ju, Yoo-Mi Kang, Dong-Hyun Lee, Sung-Ung Moon, Woon-Mok Sohn, Jae-Won Park, Tong-Soo Kim, Byoung-Kuk Na

Published in: Malaria Journal | Issue 1/2012

Login to get access

Abstract

Background

The carboxy-terminal 42 kDa region of Plasmodium vivax merozoite surface protein-1 (PvMSP-142) is a leading candidate antigen for blood stage vaccine development. However, this region has been observed to be highly polymorphic among filed isolates of P. vivax. Therefore it is important to analyse the existing diversity of this antigen in the field isolates of P. vivax. In this study, the genetic diversity and natural selection in PvMSP-142 among P. vivax Korean isolates were analysed.

Methods

A total of 149 P. vivax- infected blood samples collected from patients in Korea were used. The region flanking PvMSP-142 was amplified by PCR, cloned into Escherichia coli, and then sequenced. The polymorphic characteristic and natural selection of PvMSP-142 were analysed using the DNASTAR, MEGA4 and DnaSP programs.

Results

A total of 11 distinct haplotypes of PvMSP-142 with 40 amino acid changes, as compared to the reference Sal I sequence, were identified in the Korean P. vivax isolates. Most of the mutations were concentrated in the 33 kDa fragment (PvMSP-133), but a novel mutation was found in the 19 kDa fragment (PvMSP-119). PvMSP-142 of Korean isolates appeared to be under balancing selection. Recombination may also play a role in the resulting genetic diversity of PvMSP-142.

Conclusions

PvMSP-142 of Korean P. vivax isolates displayed allelic polymorphisms caused by mutation, recombination and balancing selection. These results will be useful for understanding the nature of the P. vivax population in Korea and for development of a PvMSP-142 based vaccine against P. vivax.
Appendix
Available only for authorised users
Literature
1.
go back to reference Holder AA, Guevara Patino JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ: Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parasitologia. 1999, 41: 409-414. Holder AA, Guevara Patino JA, Uthaipibull C, Syed SE, Ling IT, Scott-Finnigan T, Blackman MJ: Merozoite surface protein 1, immune evasion, and vaccines against asexual blood stage malaria. Parasitologia. 1999, 41: 409-414.
2.
go back to reference Holder AA: The precursor to major merozoite surface antigens: Structure and role in immunity. Prog Allergy. 1988, 41: 72-97.PubMed Holder AA: The precursor to major merozoite surface antigens: Structure and role in immunity. Prog Allergy. 1988, 41: 72-97.PubMed
3.
go back to reference Blackman MJ, Ling LT, Nicholls SC, Holder AA: Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasitol. 1991, 49: 29-34. 10.1016/0166-6851(91)90127-R.CrossRefPubMed Blackman MJ, Ling LT, Nicholls SC, Holder AA: Proteolytic processing of the Plasmodium falciparum merozoite surface protein-1 produces a membrane-bound fragment containing two epidermal growth factor-like domains. Mol Biochem Parasitol. 1991, 49: 29-34. 10.1016/0166-6851(91)90127-R.CrossRefPubMed
4.
go back to reference Blackman MJ, Holder AA: Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP-133 as a noncovalently associated complex with other fragments of the MSP1. Mol Biochem Parasitol. 1992, 50: 307-315. 10.1016/0166-6851(92)90228-C.CrossRefPubMed Blackman MJ, Holder AA: Secondary processing of the Plasmodium falciparum merozoite surface protein-1 (MSP1) by a calcium-dependent membrane-bound serine protease: shedding of MSP-133 as a noncovalently associated complex with other fragments of the MSP1. Mol Biochem Parasitol. 1992, 50: 307-315. 10.1016/0166-6851(92)90228-C.CrossRefPubMed
5.
go back to reference Soares IS, Levitus G, Souza JM, Del Portillo HA, Rodrigues MM: Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect Immun. 1997, 65: 1606-1614.PubMedCentralPubMed Soares IS, Levitus G, Souza JM, Del Portillo HA, Rodrigues MM: Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria. Infect Immun. 1997, 65: 1606-1614.PubMedCentralPubMed
6.
go back to reference Park JW, Moon SH, Yeom JS, Lim KJ, Sohn MJ, Jung WC, Cho YJ, Jeon KW, Ju W, Ki CS, Oh MD, Choe K: Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea. Clin Diagn Lab Immunol. 2001, 8: 14-20.PubMedCentralPubMed Park JW, Moon SH, Yeom JS, Lim KJ, Sohn MJ, Jung WC, Cho YJ, Jeon KW, Ju W, Ki CS, Oh MD, Choe K: Naturally acquired antibody responses to the C-terminal region of merozoite surface protein 1 of Plasmodium vivax in Korea. Clin Diagn Lab Immunol. 2001, 8: 14-20.PubMedCentralPubMed
7.
go back to reference Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan VS: Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infect Immun. 2004, 72: 5775-5782. 10.1128/IAI.72.10.5775-5782.2004.PubMedCentralCrossRefPubMed Sachdeva S, Ahmad G, Malhotra P, Mukherjee P, Chauhan VS: Comparison of immunogenicities of recombinant Plasmodium vivax merozoite surface protein 1 19- and 42-kiloDalton fragments expressed in Escherichia coli. Infect Immun. 2004, 72: 5775-5782. 10.1128/IAI.72.10.5775-5782.2004.PubMedCentralCrossRefPubMed
8.
go back to reference Pitabut N, Panichakorn J, Mahakunkijcharoen Y, Hirunpetcharat C, Looareesuwan S, Khusmith S: IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria. Southeast Asian J Trop Med Public Health. 2007, 38: 1-7.PubMed Pitabut N, Panichakorn J, Mahakunkijcharoen Y, Hirunpetcharat C, Looareesuwan S, Khusmith S: IgG antibody profile to c-terminal region of Plasmodium vivax merozoite surface protein-1 in Thai individuals exposed to malaria. Southeast Asian J Trop Med Public Health. 2007, 38: 1-7.PubMed
9.
go back to reference Yeom JS, Kim ES, Lim KJ, Oh JH, Sohn MJ, Yoo SB, Kim E, Bae I, Jung YJ, Park JW: Naturally acquired IgM antibody response to the C-terminal region of the merozoite surface protein 1 of Plasmodium vivax in Korea: use for serodiagnosis of vivax malaria. J Parasitol. 2008, 94: 1410-1414. 10.1645/GE-1484.1.CrossRefPubMed Yeom JS, Kim ES, Lim KJ, Oh JH, Sohn MJ, Yoo SB, Kim E, Bae I, Jung YJ, Park JW: Naturally acquired IgM antibody response to the C-terminal region of the merozoite surface protein 1 of Plasmodium vivax in Korea: use for serodiagnosis of vivax malaria. J Parasitol. 2008, 94: 1410-1414. 10.1645/GE-1484.1.CrossRefPubMed
10.
go back to reference Zeyrek FY, Babaoglu A, Demirel S, Erdogan DD, Ak M, Korkmaz M, Coban C: Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Am J Trop Med Hyg. 2008, 78: 729-732.PubMed Zeyrek FY, Babaoglu A, Demirel S, Erdogan DD, Ak M, Korkmaz M, Coban C: Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey. Am J Trop Med Hyg. 2008, 78: 729-732.PubMed
11.
go back to reference Pirson PJ, Perkins ME: Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J Immunol. 1985, 134: 1946-1951.PubMed Pirson PJ, Perkins ME: Characterization with monoclonal antibodies of a surface antigen of Plasmodium falciparum merozoites. J Immunol. 1985, 134: 1946-1951.PubMed
12.
go back to reference Blackman MJ, Heidrich HG, Donachie S, McBridge JS, Holder AA: A single fragment of a malaria merozoite surface protein remains on the parasite during red blood cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med. 1990, 172: 379-382. 10.1084/jem.172.1.379.CrossRefPubMed Blackman MJ, Heidrich HG, Donachie S, McBridge JS, Holder AA: A single fragment of a malaria merozoite surface protein remains on the parasite during red blood cell invasion and is the target of invasion-inhibiting antibodies. J Exp Med. 1990, 172: 379-382. 10.1084/jem.172.1.379.CrossRefPubMed
13.
go back to reference Chang SP, Gibson HL, Lee NC, Barr PJ, Hui GS: A carboxyl-terminal fragment of Plasmodium falciparum gp 195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J Immunol. 1992, 149: 548-555.PubMed Chang SP, Gibson HL, Lee NC, Barr PJ, Hui GS: A carboxyl-terminal fragment of Plasmodium falciparum gp 195 expressed by a recombinant baculovirus induces antibodies that completely inhibit parasite growth. J Immunol. 1992, 149: 548-555.PubMed
14.
go back to reference Chappel JA, Holder AA: Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1. Mol Biochem Parasitol. 1993, 60: 303-312. 10.1016/0166-6851(93)90141-J.CrossRefPubMed Chappel JA, Holder AA: Monoclonal antibodies that inhibit Plasmodium falciparum invasion in vitro recognize the first growth factor-like domain of merozoite surface protein-1. Mol Biochem Parasitol. 1993, 60: 303-312. 10.1016/0166-6851(93)90141-J.CrossRefPubMed
15.
go back to reference Burns JM, Parke LA, Daly TM, Cavacini LA, Weidanz WP, Long CA: A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii. J Immunol. 1989, 142: 2835-2840.PubMed Burns JM, Parke LA, Daly TM, Cavacini LA, Weidanz WP, Long CA: A protective monoclonal antibody recognizes a variant-specific epitope in the precursor of the major merozoite surface antigen of the rodent malarial parasite Plasmodium yoelii. J Immunol. 1989, 142: 2835-2840.PubMed
16.
go back to reference Devi YS, Mukherjee P, Yazdani SS, Shakri AR, Mazumdar S, Pandey S, Chitnis CE, Chauhan VS: Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice. Vaccine. 2007, 25: 5166-5174. 10.1016/j.vaccine.2007.04.080.CrossRefPubMed Devi YS, Mukherjee P, Yazdani SS, Shakri AR, Mazumdar S, Pandey S, Chitnis CE, Chauhan VS: Immunogenicity of Plasmodium vivax combination subunit vaccine formulated with human compatible adjuvants in mice. Vaccine. 2007, 25: 5166-5174. 10.1016/j.vaccine.2007.04.080.CrossRefPubMed
17.
go back to reference Dutta S, Kaushal DC, Ware LA, Puri SK, Kaushal NA, Narula A, Upadhyaya DS, Lanar DE: Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys. Infect Immun. 2005, 73: 5936-5944. 10.1128/IAI.73.9.5936-5944.2005.PubMedCentralCrossRefPubMed Dutta S, Kaushal DC, Ware LA, Puri SK, Kaushal NA, Narula A, Upadhyaya DS, Lanar DE: Merozoite surface protein 1 of Plasmodium vivax induces a protective response against Plasmodium cynomolgi challenge in rhesus monkeys. Infect Immun. 2005, 73: 5936-5944. 10.1128/IAI.73.9.5936-5944.2005.PubMedCentralCrossRefPubMed
18.
go back to reference Galinski BR, Barnwell JW: Plasmodium vivax : who cares?. Malar J. 2008, 7: (Suppl:S9)-CrossRef Galinski BR, Barnwell JW: Plasmodium vivax : who cares?. Malar J. 2008, 7: (Suppl:S9)-CrossRef
20.
go back to reference World Health Organization: Synopsis of the world Malaria situation in 1979. Wkly Epidemiol Rec. 1981, 56: 145-149. World Health Organization: Synopsis of the world Malaria situation in 1979. Wkly Epidemiol Rec. 1981, 56: 145-149.
21.
go back to reference Park JW, Jun G, Yeom JS: Plasmodium vivax malaria: status in the Republic of Korea following reemergence. Korean J Parasitol. 2009, 47 (Suppl): S39-S50. 10.3347/kjp.2009.47.S.S39.PubMedCentralCrossRefPubMed Park JW, Jun G, Yeom JS: Plasmodium vivax malaria: status in the Republic of Korea following reemergence. Korean J Parasitol. 2009, 47 (Suppl): S39-S50. 10.3347/kjp.2009.47.S.S39.PubMedCentralCrossRefPubMed
22.
go back to reference Park JW, Klein TA, Lee HC, Pacha LA, Ryu SH, Yeom JS, Moon SH, Kim TS, Chai JY, Oh MD, Choe KW: Vivax malaria: A continuing health threat to the Republic of Korea. Am J Trop Med Hyg. 2003, 69: 159-167.PubMed Park JW, Klein TA, Lee HC, Pacha LA, Ryu SH, Yeom JS, Moon SH, Kim TS, Chai JY, Oh MD, Choe KW: Vivax malaria: A continuing health threat to the Republic of Korea. Am J Trop Med Hyg. 2003, 69: 159-167.PubMed
23.
go back to reference Yeom JS, Kim TS, Oh S, Sim JB, Barn JS, Kim HJ, Kim YA, Ahn SY, Shin MY, Yoo JA, Park JW: Plasmodium vivax malaria in the Republic of Korea during 2004–2005: Changing patterns of infection. Am J Trop Med Hyg. 2007, 76: 865-868.PubMed Yeom JS, Kim TS, Oh S, Sim JB, Barn JS, Kim HJ, Kim YA, Ahn SY, Shin MY, Yoo JA, Park JW: Plasmodium vivax malaria in the Republic of Korea during 2004–2005: Changing patterns of infection. Am J Trop Med Hyg. 2007, 76: 865-868.PubMed
24.
go back to reference Lim CS, Kim SH, Kwon SI, Song JW, Song KJ, Lee KN: Analysis of Plasmodium vivax merozoite surface protein-1 gene sequences from resurgent Korean isolates. Am J Trop Med Hyg. 2000, 62: 261-265.PubMed Lim CS, Kim SH, Kwon SI, Song JW, Song KJ, Lee KN: Analysis of Plasmodium vivax merozoite surface protein-1 gene sequences from resurgent Korean isolates. Am J Trop Med Hyg. 2000, 62: 261-265.PubMed
25.
go back to reference Kim SH, Hwang SY, Shin JH, Moon CS, Kim DW, Kho WG: Molecular genetic characterization of the merozoite surface protein 1 gene of Plasmodium vivax from reemerging Korean isolates. Clin Vaccine Immunol. 2009, 16: 733-738. 10.1128/CVI.00493-08.PubMedCentralCrossRefPubMed Kim SH, Hwang SY, Shin JH, Moon CS, Kim DW, Kho WG: Molecular genetic characterization of the merozoite surface protein 1 gene of Plasmodium vivax from reemerging Korean isolates. Clin Vaccine Immunol. 2009, 16: 733-738. 10.1128/CVI.00493-08.PubMedCentralCrossRefPubMed
26.
go back to reference Choi YK, Choi KM, Park MH, Lee EG, Kim YJ, Lee BC, Cho SH, Rhie HG, Lee HS, Yu JR, Lee JS, Kim TS, Kim JY: Rapid dissemination of newly introduced Plasmodium vivax genotypes in South Korea. Am J Trop Med Hyg. 2010, 82: 426-432. 10.4269/ajtmh.2010.09-0245.PubMedCentralCrossRefPubMed Choi YK, Choi KM, Park MH, Lee EG, Kim YJ, Lee BC, Cho SH, Rhie HG, Lee HS, Yu JR, Lee JS, Kim TS, Kim JY: Rapid dissemination of newly introduced Plasmodium vivax genotypes in South Korea. Am J Trop Med Hyg. 2010, 82: 426-432. 10.4269/ajtmh.2010.09-0245.PubMedCentralCrossRefPubMed
27.
go back to reference Moon SU, Lee HW, Kim JY, Na BK, Cho SH, Lin K, Sohn WM, Kim TS: High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar. Acta Trop. 2009, 109: 30-36. 10.1016/j.actatropica.2008.09.006.CrossRefPubMed Moon SU, Lee HW, Kim JY, Na BK, Cho SH, Lin K, Sohn WM, Kim TS: High frequency of genetic diversity of Plasmodium vivax field isolates in Myanmar. Acta Trop. 2009, 109: 30-36. 10.1016/j.actatropica.2008.09.006.CrossRefPubMed
28.
go back to reference Thakur A, Alam MT, Sharma YD: Genetic diversity in the C-terminal 42 kDa region of merozoite surface protein-1 of Plasmodium vivax (PvMSP-142) among Indian isolates. Acta Trop. 2008, 108: 58-63. 10.1016/j.actatropica.2008.08.011.CrossRefPubMed Thakur A, Alam MT, Sharma YD: Genetic diversity in the C-terminal 42 kDa region of merozoite surface protein-1 of Plasmodium vivax (PvMSP-142) among Indian isolates. Acta Trop. 2008, 108: 58-63. 10.1016/j.actatropica.2008.08.011.CrossRefPubMed
29.
go back to reference Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24: 1596-1599. 10.1093/molbev/msm092.CrossRefPubMed Tamura K, Dudley J, Nei M, Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol. 2007, 24: 1596-1599. 10.1093/molbev/msm092.CrossRefPubMed
30.
go back to reference Librado P, Rozas J: DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009, 25: 1451-1452. 10.1093/bioinformatics/btp187.CrossRefPubMed Librado P, Rozas J: DnaSP v5: a software for comprehensive analysis of DNA polymorphism data. Bioinformatics. 2009, 25: 1451-1452. 10.1093/bioinformatics/btp187.CrossRefPubMed
31.
go back to reference Nei M, Gojobori T: Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986, 3: 418-426.PubMed Nei M, Gojobori T: Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol Biol Evol. 1986, 3: 418-426.PubMed
32.
go back to reference Tajima F: Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989, 123: 585-595.PubMedCentralPubMed Tajima F: Statistical method for testing the neutral mutation hypothesis by DNA polymorphism. Genetics. 1989, 123: 585-595.PubMedCentralPubMed
34.
go back to reference Ellis RD, Sagara I, Doumbo O, Wu Y: Blood stage vaccines for Plasmodium falciparum: current status and the way forward. Hum Vaccin. 2010, 6: 627-634. 10.4161/hv.6.8.11446.PubMedCentralCrossRefPubMed Ellis RD, Sagara I, Doumbo O, Wu Y: Blood stage vaccines for Plasmodium falciparum: current status and the way forward. Hum Vaccin. 2010, 6: 627-634. 10.4161/hv.6.8.11446.PubMedCentralCrossRefPubMed
35.
go back to reference Malkin E, Long CA, Stowers AW, Zou L, Singh S, MacDonald NJ, Narum DL, Miles AP, Orcutt AC, Muratova O, Moretz SE, Zhou H, Diouf A, Fay M, Tierney E, Leese P, Mahanty S, Miller LH, Saul A, Martin LB: Phase 1 study of two merozoite surface protein 1 (MSP 142) vaccines for Plasmodium falciparum malaria. PLoS Clin Trial. 2007, 2: e12-10.1371/journal.pctr.0020012.CrossRef Malkin E, Long CA, Stowers AW, Zou L, Singh S, MacDonald NJ, Narum DL, Miles AP, Orcutt AC, Muratova O, Moretz SE, Zhou H, Diouf A, Fay M, Tierney E, Leese P, Mahanty S, Miller LH, Saul A, Martin LB: Phase 1 study of two merozoite surface protein 1 (MSP 142) vaccines for Plasmodium falciparum malaria. PLoS Clin Trial. 2007, 2: e12-10.1371/journal.pctr.0020012.CrossRef
36.
go back to reference Huaman MC, Martin LB, Malkin E, Narum DL, Miller LH, Mahanty S, Long CA: Ex vivo cytokine and memory T cell responses to the 42-kDa fragment of Plasmodium falciparum merozoite surface protein-1 in vaccinated volunteers. J Immunol. 2008, 180: 1451-1461.CrossRefPubMed Huaman MC, Martin LB, Malkin E, Narum DL, Miller LH, Mahanty S, Long CA: Ex vivo cytokine and memory T cell responses to the 42-kDa fragment of Plasmodium falciparum merozoite surface protein-1 in vaccinated volunteers. J Immunol. 2008, 180: 1451-1461.CrossRefPubMed
37.
go back to reference Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, Malkin E, Leach A, Soisson LA, Milman JB, Otieno L, Holland CA, Polhemus M, Remich SA, Ockenhouse CF, Cohen J, Ballou WR, Martin SK, Angov E, Stewart VA, Lyon JA, Heppner DG, Withers MR, MSP-1 Malaria Vaccine Working Group: Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in western Kenya. PLoS One. 2009, 4: e4708-10.1371/journal.pone.0004708.PubMedCentralCrossRefPubMed Ogutu BR, Apollo OJ, McKinney D, Okoth W, Siangla J, Dubovsky F, Tucker K, Waitumbi JN, Diggs C, Wittes J, Malkin E, Leach A, Soisson LA, Milman JB, Otieno L, Holland CA, Polhemus M, Remich SA, Ockenhouse CF, Cohen J, Ballou WR, Martin SK, Angov E, Stewart VA, Lyon JA, Heppner DG, Withers MR, MSP-1 Malaria Vaccine Working Group: Blood stage malaria vaccine eliciting high antigen-specific antibody concentrations confers no protection to young children in western Kenya. PLoS One. 2009, 4: e4708-10.1371/journal.pone.0004708.PubMedCentralCrossRefPubMed
38.
go back to reference Pasay MC, Cheng Q, Rzepczyk C, Saul A: Dimorphism of the C-terminus of the Plasmodium vivax merozoite surface protein-1. Mol Biochem Parasitol. 1995, 70: 217-219. 10.1016/0166-6851(95)00015-S.CrossRefPubMed Pasay MC, Cheng Q, Rzepczyk C, Saul A: Dimorphism of the C-terminus of the Plasmodium vivax merozoite surface protein-1. Mol Biochem Parasitol. 1995, 70: 217-219. 10.1016/0166-6851(95)00015-S.CrossRefPubMed
39.
go back to reference Soares IS, Barnwell JW, Ferreira MU, Gomes Da Cunha M, Laurino JP, Laurino JP, Castilho BA, Rodrigues MM: A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Mol Med. 1999, 5: 459-470.PubMedCentralPubMed Soares IS, Barnwell JW, Ferreira MU, Gomes Da Cunha M, Laurino JP, Laurino JP, Castilho BA, Rodrigues MM: A Plasmodium vivax vaccine candidate displays limited allele polymorphism, which does not restrict recognition by antibodies. Mol Med. 1999, 5: 459-470.PubMedCentralPubMed
40.
go back to reference Putaporntip C, Jongwutiwes S, Seethamchai S, Kanbara H, Tanabe K: Intragenic recombination in the 30 portion of the merozoite surface protein-1 gene of Plasmodium vivax. Mol Biochem Parasitol. 2000, 109: 111-119. 10.1016/S0166-6851(00)00238-3.CrossRefPubMed Putaporntip C, Jongwutiwes S, Seethamchai S, Kanbara H, Tanabe K: Intragenic recombination in the 30 portion of the merozoite surface protein-1 gene of Plasmodium vivax. Mol Biochem Parasitol. 2000, 109: 111-119. 10.1016/S0166-6851(00)00238-3.CrossRefPubMed
41.
go back to reference Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneko A, Kanbara H, Hattori T, Tanabe K: Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc Natl Acad Sci USA. 2002, 99: 16348-16353. 10.1073/pnas.252348999.PubMedCentralCrossRefPubMed Putaporntip C, Jongwutiwes S, Sakihama N, Ferreira MU, Kho WG, Kaneko A, Kanbara H, Hattori T, Tanabe K: Mosaic organization and heterogeneity in frequency of allelic recombination of the Plasmodium vivax merozoite surface protein-1 locus. Proc Natl Acad Sci USA. 2002, 99: 16348-16353. 10.1073/pnas.252348999.PubMedCentralCrossRefPubMed
42.
go back to reference Dias S, Longacre S, Escalante AA, Udagama-Randeniya PV: Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka. Infect Genet Evol. 2011, 11: 145-156. 10.1016/j.meegid.2010.09.007.CrossRefPubMed Dias S, Longacre S, Escalante AA, Udagama-Randeniya PV: Genetic diversity and recombination at the C-terminal fragment of the merozoite surface protein-1 of Plasmodium vivax (PvMSP-1) in Sri Lanka. Infect Genet Evol. 2011, 11: 145-156. 10.1016/j.meegid.2010.09.007.CrossRefPubMed
43.
go back to reference Honma H, Kim JY, Palacpac NM, Mita T, Lee W, Horii T, Tanabe K: Recent increase of genetic diversity in Plasmodium vivax population in the Republic of Korea. Malar J. 2011, 10: 257-10.1186/1475-2875-10-257.PubMedCentralCrossRefPubMed Honma H, Kim JY, Palacpac NM, Mita T, Lee W, Horii T, Tanabe K: Recent increase of genetic diversity in Plasmodium vivax population in the Republic of Korea. Malar J. 2011, 10: 257-10.1186/1475-2875-10-257.PubMedCentralCrossRefPubMed
44.
go back to reference Pacheco MA, Poe AC, Collins WE, Lal AA, Tanabe K, Kariuki SK, Udhayakumar V, Escalante AA: A comparative study of the genetic diversity of the 42 kDa fragment of the merozoite surface protein-1 in Plasmodium falciparum and P. vivax. Infect Genet Evol. 2007, 7: 180-187. 10.1016/j.meegid.2006.08.002.PubMedCentralCrossRefPubMed Pacheco MA, Poe AC, Collins WE, Lal AA, Tanabe K, Kariuki SK, Udhayakumar V, Escalante AA: A comparative study of the genetic diversity of the 42 kDa fragment of the merozoite surface protein-1 in Plasmodium falciparum and P. vivax. Infect Genet Evol. 2007, 7: 180-187. 10.1016/j.meegid.2006.08.002.PubMedCentralCrossRefPubMed
45.
go back to reference Escalante AA, Cornejo OE, Rojas A, Udhayakumar V, Lal AA: Assessing the effect of natural selection in malaria parasites. Trends Parasitol. 2004, 20: 388-395. 10.1016/j.pt.2004.06.002.CrossRefPubMed Escalante AA, Cornejo OE, Rojas A, Udhayakumar V, Lal AA: Assessing the effect of natural selection in malaria parasites. Trends Parasitol. 2004, 20: 388-395. 10.1016/j.pt.2004.06.002.CrossRefPubMed
46.
Metadata
Title
Genetic polymorphism and natural selection in the C-terminal 42 kDa region of merozoite surface protein-1 among Plasmodium vivax Korean isolates
Authors
Jung-Mi Kang
Hye-Lim Ju
Yoo-Mi Kang
Dong-Hyun Lee
Sung-Ung Moon
Woon-Mok Sohn
Jae-Won Park
Tong-Soo Kim
Byoung-Kuk Na
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Malaria Journal / Issue 1/2012
Electronic ISSN: 1475-2875
DOI
https://doi.org/10.1186/1475-2875-11-206

Other articles of this Issue 1/2012

Malaria Journal 1/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine